Curr Med Chem 19: 126132
Development of databases on iodine in foods and dietary supplements
Hello Gorgeous discusses it for longevity-curious clients who've exhausted basics sleep hygiene, NAD+, and labs and want an NP-guided next step
Eli Lilly and Company announced positive results from the pivotal phase 3 TRIUMPH-1 trial of retatrutide, an investigational triple hormone receptor agonist, demonstrating substantial weight loss and meaningful improvements in moderate-to-severe obstructive sleep apnea (OSA)
The elderly, and those affected by chronic disease, especially the respiratory and immuno- compromised, seem to be most vulnerable to COVID-19 infection and its complications [2]
MONDAY, July 3, 2023 (HealthDay News) The weight-loss drug Ozempic could be dangerous for a patient undergoing anesthesia, according to a new warning from the American Society of Anesthesiologists